BIOMARIN PHARMACEUTICAL INC - Director's Dealing 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2017-04-28

Reporting Person: Mueller Brian (SVP, Corporate Controller)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-04-28	Common Stock	A	270	$70.304	Acquired	18350	Direct
2017-05-08	Common Stock	S	4882	$91.17	Disposed	13468	Direct
2017-05-08	Common Stock	M	2600	$21.51	Acquired	16068	Direct
2017-05-08	Common Stock	S	2600	$93.17	Disposed	13468	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-08	Stock Option (Right to buy Common Stock)	$21.51	M	2600	Disposed	2020-05-11	Common Stock (2600)	Direct

F1: Represents shares acquired by the reporting person on April 28, 2017, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Trade made pursuant to a 10b5-1 plan executed on March 13, 2017.

F3: All shares were sold at the same price.

F4: Option grant vests 12/48th on March 22, 2018 and 1/48th on the 22nd day of each month thereafter.